Moderate to Severe Psoriasis and Psoriatic Arhtritis: Biologic Drugs
Combination therapy for neuropathic pain
Front Immunol (2019) 10:1587
GLP-1 class: do not combine Combining semaglutide with other GLP-1 agonists (liraglutide, dulaglutide) or with GLP-1-containing multi-agonists (tirzepatide, retatrutide) risks unpredictable GLP-1 receptor overstimulation, compounded GI toxicity, and uncontrolled metabolic effects
It can help correct deficiencies, improve overall well-being, and support your weight management journey
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals predispositions in GLP-1 and GIPR pathways (rs6923761, rs1800437) that may help provide context for how your body responds to semaglutide metabolism and signaling